Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  BLOOD BANKING AND BLOOD PRODUCTS
A Global Strategic Business Report

This report analyzes the worldwide markets for Blood Banking & Blood Products in Millions of US$. The specific product segments analyzed are Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 206 companies, including leading blood banks such as AABB, America’s Blood Centers, American Red Cross, Canadian Blood Services, CorCell Companies, Inc., Cord Blood Registry, Japan Red Cross, Lifebank Corp, National Blood Foundation, New England Cord Blood Bank, Inc., New York Blood Center, and VITA 34 AG. Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson, BioMerieux SA, Caridian BCT, Inc., Chiron, CSL Behring, Daxor Corporation, Fenwal Inc., Fresenius SE, Gambro AB, Gen-Probe Incorporated, Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and ZymeQuest, Inc. Leading Players discussed under the Plasma Fractionation segment include Baxter International Inc., Bio Products Laboratory, CSL Limited, CSL Bioplasma, Grifols, Kedrion, Laboratorie Francais du Fractionnement et des Biotechnologies, Octapharma, Sanquin, and Talecris Biotherapeutics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1028  PAGES:    960
PRICE:    $3950  DATE:       October 2008
COMPANIES:  206  MARKET DATA TABLES:   376
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  BLOOD BANKING AND BLOOD PRODUCTS (Complete Report) Pages : 960   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS5$100
   Study Reliability and Reporting Limitations...I-1  
   Disclaimers...I-2
Data Interpretation & Reporting Level...I-2
  
   Quantitative Techniques & Analytics...I-3
Product Definitions and Scope of Study...I-3
Blood Components and Plasma Products...I-3
Whole Blood & Cellular Components...I-3
  
   WBCs...I-4
RBCs...I-4
Platelets...I-4
Plasma Fractions...I-4
Fresh Frozen Plasma...I-4
Albumin Fractions...I-4
Factor VIII...I-4
  
   Factor IX and Factor IX Complex...I-5
Fibrin/Thrombin...I-5
Equipment, Blood Tests and Consumables...I-5
Automated Analyzers for Blood Analysis...I-5
Blood Tests...I-5
Consumables...I-5
  
II. EXECUTIVE SUMMARY122$2250
  1. Market Overview...II-15 $1100  
   Healthcare Scares Propel the Market...II-1
Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts...II-1
1$100
   Worldwide Blood Banking and Blood Products Market at a Glance...II-2
Current & Future Analysis...II-2
Analysis by Geographic Region...II-2
1$100
   Analysis by Product Segment...II-3
World Blood Components and Plasma Market Analysis in Units...II-3
Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country – USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)...II-3
1$300
   Table 2: World 10-Year Perspective for Blood Components and Plasma by Region/Country – Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)...II-41$300
   Red Blood Cells – A Key Blood Component and a Major Contributor...II-5
Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country – USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)...II-5

Table 4: World 10-Year Perspective for Red Blood Cells by Region/Country – Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)...II-5
1$300
  2. Market Trends & Issues...II-67 $800  
   New Infections – A Continuous Threat ...II-6
Safety and Availability: The Core Issues...II-6
1$100
   Decontamination: A Viable Process...II-7
New Processes for Safer Blood Supply...II-7
Innovative Procedures Help Blood Conservation...II-7
Autologous Transfusion Strapping up for High Growth...II-7
Enzyme Converted Cells Set to Rule the Industry...II-7
1$100
   Blood Unavailability: Substitutes to the Rescue...II-8
Transfusions: Hospitals Making Way for Others...II-8
Computer Identification Helps Patients...II-8
1$100
   SARS: A Case of Mistaken Identity?...II-9
Pooling: Economical HIV Testing...II-9
Private Cord Blood Banking: Flying High Despite Opposition...II-9
Consolidation Whittles Down Number of Market Players...II-9
1$100
   Table 5: Leading Players in World Market for Plasma Fractionation (2005): Percentage Breakdown of Fractionation Capacity for CSL Limited, Telecris, Baxter, Grifols, Octapharma and Others (includes corresponding Graph/Chart)...II-10
Automation of Blood Banking – Nearing the Efficiency Frontier?...II-10
Automated Instrumentation Taking the Front Seat...II-10
Table 6: World Market for Blood Bank Technology (2004): Percentage Breakdown of Revenues by Segment – Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage, and Pathogen Inactivation (includes corresponding Graph/Chart)...II-10
1$300
   Table 7: Leading Players in the World Market for Automated Collection of Blood Components using Apheresis Technology (2005): Percentage Breakdown of Revenues for Gambro, Baxter, Haemonetics, Fresenius, and Others (includes corresponding Graph/Chart)...II-11
Plasma Market: Automation Making Inroads...II-11
The RBC Market – Slow to Catch Up...II-11
Automation of Testing – Yet to Mature...II-11
1$300
   Automation to Suffice Shortage Problems...II-12
How Near to the Efficiency Frontier?...II-12
1$100
  3. Product Overview...II-1314 $1400  
   Blood Banking and Blood Products Industry...II-13
Blood Components and Plasma Products...II-13
Equipment, Blood Tests and Consumables...II-13
Automated Analyzers for Blood Analysis...II-13
Blood Tests...II-13
1$100
   Consumables...II-14
Blood Collection Equipment...II-14
Blood Collection Monitors...II-14
Blood Donor Couches...II-14
Blood Processing Equipment...II-14
Blood Bank Centrifuges...II-14
Plasma Thawing...II-14
Blood Cell Separators...II-14
1$100
   Blood Storage Equipment...II-15
Blood Bags...II-15
Platelet Agitators...II-15
Blood Bank Refrigerators...II-15
Blood – A Primer...II-15
Ionic Structure...II-15
1$100
   Blood Components and their Applications...II-161$100
   Blood Constituents...II-17
Plasma...II-17
Red Blood Cells (RBC)...II-17
1$100
   Blood Count...II-18
Platelets...II-18
Table 8: Platelets (Leucodepleted) Issued by Select Region/ Agency (2005) (includes corresponding Graph/Chart)...II-18
1$300
   White Blood Cells (WBC)...II-19
Derivative Products of Blood or Plasma Fractions...II-19
Plasma Protein and Fractionation...II-19
The Need...II-19
1$100
   Fresh Frozen Plasma...II-20
Other Plasma Fractions...II-20
Albumin Fractions...II-20
Albumin Usage Rising in Profile, Wastage Worries Run Deep...II-20
Immunoglobulins...II-20
1$100
   Table 9: Leading Countries in IVIg Usage Rates in Grams per 1000 Population (includes corresponding Graph/Chart)...II-21
Hyper-Immune Immunoglobulin...II-21
Factor VIII...II-21
Table 10: Leading Players in World Market for Factor VIII (2006): Percentage Breakdown of Revenues for Baxter, Bayer (Kogenate), CSL Behring (Helixate) and Wyeth (includes corresponding Graph/Chart)...II-21
Factor IX and Factor IX Complex...II-21
1$300
   Fibrin/Thrombin...II-22
Consumption of Blood Based on Type of Surgery/ Accident (In Units)...II-22
Table 11: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Region/Country – USA, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart)...II-22

Table 12: World Market for Plasma Derivatives (2006): Percentage Breakdown of Revenues by Product Type – IVIg, Factor VIII, Albumin, Hyperimmunes, Factor IX and Others (includes corresponding Graph/Chart)...II-22
1$300
   Table 13: Plasma Collection in Select Countries in Thousand Liters (2005) (includes corresponding Graph/Chart)...II-23
Recombinant Products...II-23
Therapeutic Uses of Plasma Products...II-23
Albumin Products...II-23
1$300
   Immunoglobulins...II-24
Intravenous Immunoglobulin (IVIg)...II-24
Normal Immunoglobulin (IMIg)...II-24
CMV Immunoglobulin...II-24
Hepatitis B Immunoglobulin...II-24
Rh(D) Immunoglobulin...II-24
Tetanus Immunoglobulin IM...II-24
1$100
   Zoster Immunoglobulin...II-25
Plasma Derived Coagulant Products...II-25
Biostate®...II-25
Ceprotin®...II-25
Factor VII Concentrate...II-25
Factor XI Concentrates...II-25
Feiba VH® Inhibitor Treatment...II-25
Fibrogammin P®...II-25
Monofix®-VF...II-25
1$100
   ProthrombinexTM-HT...II-26
Thrombotrol®-VF...II-26
1$100
  4. Blood Collection Methods...II-2712 $1100  
   Banking the Natural Blood Resources...II-27
Blood Banks...II-27
Blood Banking...II-27
Blood Transfusion...II-27
Role of Blood Banks...II-27
Blood Donor: The Epicenter of the Process...II-27
1$100
   Eligibility Criteria for the Donor...II-28
The Basics of Blood Donation – Myths Exploded & Other Facts...II-28
1$100
   Table 14: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/Agency (2004 & 2005) (includes corresponding Graph/Chart)...II-291$300
   Table 15: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (2005) (includes corresponding Graph/Chart)...II-30
Collection Methods...II-30
Blood Donation: The Process...II-30
Types of Blood Donation...II-30
Directed Blood Donations...II-30
1$300
   Autologous Blood Donation...II-31
Alternative Usage of Patient’s Own Blood...II-31
General Blood Donation...II-31
Hemodilution...II-31
Wound Drainage...II-31
Cell Saver...II-31
The Method...II-31
1$100
   Blood Salvaging...II-32
Blood Collection Centers...II-32
Blood Collection Management System...II-32
A Historical Retrospective...II-32
Blood Collection Centers...II-32
Types of Blood Collection Centers...II-32
Cord Blood Banks...II-32
1$100
   Profit Collection Centers...II-33
Military Blood Banks...II-33
Hospital Blood Banks...II-33
Community Blood Banks...II-33
Non-Profit Collection Centers...II-33
1$100
   Blood Processing...II-34
Blood Typing...II-34
1$100
   Rh Blood Group System...II-35
ABO Blood Group System...II-35
Blood Types and their Compatibility...II-35
1$100
   Table 16: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart)...II-36
Blood Test...II-36
Blood Culture...II-36
The Costs...II-36
1$300
   History of Blood Banking...II-37
2$200
  5. The Changing Landscape of Transfusion Technologies & Tests...II-393 $300  
   Blood Transfusion: A Backdrop...II-39
Massive Transfusion...II-39
Complications and Risks Due to Transfusion...II-39
1$100
   Circulatory Overload...II-40
Graft Versus Host Disease (GVHD)...II-40
Haemolytic Transfusion Reactions...II-40
Iron Overload...II-40
Bacterial Contamination...II-40
Thrombophlebitis...II-40
Allergic Reactions...II-40
1$100
   Air Embolism...II-41
Hyperkalaemia...II-41
Changing Role of Blood Banking Technology...II-41
1$100
  6. Blood Transfusion: The Process, Tests/Technologies...II-422 $200  
   Cross Matching...II-42
Blood Donor/Recipient Screening...II-42
Blood Typing...II-42
Leukoreduction...II-42
1$100
   Leukocyte Reduction Specification Standards/Filters...II-43
Coombs Test...II-43
1$100
  7. Alternatives to Blood Transfusion: A Real Threat to the Industry...II-443 $300  
   Bloodless Surgery...II-44
Therapeutic Apheresis...II-44
Plasmapheresis...II-44
Plateletpheresis...II-44
1$100
   Leukapheresis...II-45
Volume Expanders...II-45
Colloids...II-45
Albumin...II-45
Dextrans...II-45
Hydroxyethyl Starch...II-45
Crystalloids...II-45
1$100
   Blood Growth Factor Therapies – Newer Alternatives to Transfusion...II-46
1$100
  8. Blood Substitutes...II-473 $300  
   Blood Substitutes Under Development by Manufacturers...II-471$100
   Synthetic Blood Manufacturers/Developers...II-48
Alliance Pharmaceuticals Corp. (USA)...II-48
Biopure Corporation (USA)...II-48
Enzon Pharmaceuticals (USA)...II-48
1$100
   Hemosol Inc. (Canada)...II-49
Northfield Laboratories Inc. (USA)...II-49
Synthetic Blood International, Inc. (USA)...II-49
1$100
  9. Product Introductions/Innovations...II-505 $500  
   Gen-Probe Introduces APTIMA® HPV Assay...II-50
Olympus AU680® Analyzer Offers an Automated HbA1c Assay...II-50
Haemonetics Unveils New Plasma Collection Software...II-50
Pall Unveils Acrodose™ PLus System...II-50
1$100
   Z-Medica Rolls Out Rapid Blood Clotting Products in the Consumer Market...II-51
Dade Behring Launches the Quadriga BeFree System...II-51
Swedish Inventors Develop New Processing System...II-51
Canada Invents New Method for Monitoring Blood and Blood Products...II-51
Terumo Launches Improvised Bags For Safe Blood Collection...II-51
1$100
   Haemonetics Launches Cymbal Automated Blood Collection System...II-52
Illinois Inventors Introduces New Systems to Prepare Blood Products...II-52
Abbott Unveils Two New Products for Blood Banks...II-52
1$100
   Cell Robotics Introduces New Lasette P 200...II-53
Beckman’s COULTER® LH 750 Hematology Analyzers Hit the Market...II-53
Haemonetics Unveils MCS®+ - Improved Red Cell Collection Technology...II-53
Baxter Launches ALYX Component Collection System...II-53
1$100
   Grifols’ DG Gel® Revolutionizes Column Agglutination...II-54
BioMérieux Introduces DAVINCI® ...II-54
Pall Develops Novel Blood Filtration Membrane...II-54
1$100
  10. Products in Pipeline & Technology Update...II-552 $200  
   From Clinical Trials to Clinics...II-55
Cerus Receives CE Mark Approval for the Intercept Blood System for Platelets...II-55
Haemonetics Wins FDA Approval for the ACP 215 System...II-55
Biomerieux’ Polycarbonate BacT/ALERT Receives US FDA Clearance...II-55
1$100
   Pall’s eBDS Receives Green Signal from FDA...II-56
CardioPAT™ Surgical Blood Salvage System...II-56
PCS® 2 – Set to Enhance Plasma Quality...II-56
Dade Behring’s D-Dimer Assay Strapping up for Roll Out...II-56
1$100
  11. Recent Industry Activity...II-5730 $1600  
   Global Med Technologies® Acquires eDonor®...II-57
Immucor Snaps Up BioArray Solutions...II-57
Global Med Technologies Acquires Inlog...II-57
Gen-Probe to Acquire Innogenetics...II-57
1$100
   ProMetic to Hold Major Share in Pathogen Removal and Diagnostic Technologies...II-58
ThermoGenesis Partners with GE Healthcare...II-58
ThermoGenesis Ties Up with University of California...II-58
Gambro Inks Preliminary Agreement with S.C.M S.r.l....II-58
ITL Extends Agreement with American Red Cross...II-58
CSL Enters into Agreements with Héma-Québec and Canadian Blood Services...II-58
1$100
   Gambro Launches Bloodline Manufacturing Plant in Czech Republic...II-59
Global Med Technologies® and Mid Coast Sign a License Agreement...II-59
Global Med Technologies® Inks an Agreement with FBC...II-59
1$100
   ZymoGenetics Obtains FDA Approval for Marketing Recothrom...II-60
CellaVision Enters into a Two-Year Manufacturing Agreement with Kitron AB...II-60
VITA 34 and BKK Gruner + Jahr Sign Cooperation Agreement...II-60
Haemonetics Bags FDA Clearance for eLynx...II-60
Haemonetics Obtains FDA Approval for Symphony 2.0 Software...II-60
1$100
   Thermogenesis Receives CE Mark Approval for Marrowxpress™...II-61
Olympus PK 7300® Automated Microplate System Bags FDA Clearance...II-61
ABL80 FLEX CO-OX Blood Gas Analyzer Receives FDA Clearance...II-61
PK® Blood Grouping and Phenotyping Reagents Get FDA Approval...II-61
1$100
   Blood Banks with quality Transfusion Therapy to Come Up in Indian Metros...II-62
Haemonetics Acquires Infonalé...II-62
Gambro BCT Changes its Name to Caridian BCT...II-62
Terumo Acquires Salymed...II-62
Fresenius Takes Over Renal Solutions...II-62
PerkinElmer Completes ViaCell Acquisition...II-62
1$100
   Texas Cord Blood Bank Expands Cord Blood Collection Network...II-63
Inverness Medical Acquires HemoSense...II-63
Haemonetics Acquires Haemoscope’ Hemostasis Analyzer Business Unit...II-63
NxStage Medical Completes Medisystems Acquisition...II-63
1$100
   CordLife Establishes Cord Blood Bank in Indonesia...II-64
Xinjiang Deyuan Begins Construction of a New Blood Product Plant...II-64
Cord Blood America Acquires Curesource...II-64
Grifols and Cerus Join Hands to Commercialize Cerus’ Intercept Blood System...II-64
Fresenius Kabi Signs Agreement to Acquire Kyorin Pharmaceutical...II-64
1$100
   Immucor and American Red Cross Ink Supply Agreement...II-65
Haemonetics Signs Contract with Octapharma...II-65
SFDA Revokes Drug Approval and Production Permit of Guangdong Bioyee...II-65
Immucor Obtains Clearance from FDA for Marketing Galileo Echo...II-65
Novartis Receives Approval for PROCLEIX® TIGRIS® System...II-65
Thermogenesis Obtains FDA Approval for Autoxpress™...II-65
1$100
   CSL Receives Approval for Rhophylac®...II-66
CSL Expands Haemate® P Business...II-66
ViaCell to Expand ViaCord Processing Laboratory...II-66
Cryobanks to Set Up a Cord Blood Bank in Thailand...II-66
Grifols to Manage Four New Plasma Collection Centers in US...II-66
Hualan Biological Acquires Chongqing Yituo...II-66
1$100
   CyGenics to Focus on Cord Blood Banking...II-67
Cord Blood America Acquires CorCell...II-67
Stemcyte to Establish Cord Blood Bank in India...II-67
Baxter Divests Transfusion Therapies Business...II-67
1$100
   Cerus Obtains Approval for Intercept Blood System in Germany...II-68
Cangene Obtains Health Canada Approval for Anti-Hepatitis B Blood Product...II-68
Cord Blood America Inks Marketing Agreement with MSBCBS...II-68
BCCL Acquires Stake in Life Cell...II-68
bioMérieux and AdvanDx Sign Distribution Agreement for Rapid Diagnostic Tests...II-68
1$100
   Vita 34 International AG Expands Umbilical Cord Blood Banking Services...II-69
Data Innovations to Develop Data Capture and Reporting System for Fenwal...II-69
SunTech Medical Group Acquires Empirical Technologies...II-69
Cord Blood America Acquires Cryobank...II-69
1$100
   Kalbe Acquires Stake in CyGenics’s Subsidiary CordLife Indonesia...II-70
Cryobanks International Signs Letters of Intent with MedStem Services...II-70
Cryobanks International Opens Cord Blood Stem Cell Bank...II-70
DomaniCell Initiates Family Cord Blood Banking Program in Hospitals...II-70
1$100
   Cryobanks International Grants License for Cord Blood Processing System...II-71
Community Blood Center Bags Contract...II-71
Wilkes Medical Center Grants License for SafeTrace Tx...II-71
Biosite Collaborates with HUG Research Hospital...II-71
Pliva Terminates Agreement with Mayne...II-71
1$100
   Mississippi Blood Services Secures Contract...II-72
APL Partners with Omscan...II-72
DomaniCell Receives Stem Cell Banking License...II-72
ThermoGenesis Enters into an Agreement with Cord Blood Registry...II-72
ZLB Enters into Plasma Deal with BCA...II-72
1$100
   ViaCell and Pall Secure FDA Approval for ViaCord® Collection Kit...II-73
Pall Secures Contract from NBS to Supply ‘Leukotrap’ Filtration System...II-73
Biotest and Sanquin to Form Joint Venture for Plasma Production...II-73
1$100
   Consorta Signs Partnership Agreement with GSABC...II-74
Haemonetics Signs Supply Agreement with Canadian Blood Services...II-74
Haemonetics Extends the Agreement with American Red Cross...II-74
1$100
   Novation and Abbott Enter into a Technology Agreement...II-75
Olympus Redefines the Agreement with Biotest...II-75
Cerus to Receive Marketing Rights over Baxter’s INTERCEPT Blood System...II-75
1$100
   CyGenics to Establish a New Cord Blood Banking Company...II-76
UKCBB to Establish a Modern Laboratory in UMIC’s New CTF...II-76
St. John’s Medical Center Procures Wyndgate’s SafeTrace Tx...II-76
Florida`s Blood Centers Acquires South Florida Blood Banks...II-76
1$100
   BioStem Takes Over Cryobanks International...II-77
FCBS Creates a Niche for itself by designing Cord Blood Stem Cells and Offers Public
  Donation Option...II-77
Pall Signs Sale Agreement with Green Cross for Blood Filters...II-77
TCBB Starts Collecting Donations for Cord Blood...II-77
Pall Received FDA Clearance to Market New Pall Acrodose™ PL System...II-77
1$100
   CordLife Singapore Receives AABB Accreditation...II-78
ITL and ARC Enter into an Agreement for Blood Bank Equipment...II-78
NBA and UKT Merge to Form NHSBT...II-78
BioMérieux and ExonHit Extend Collaboration to Develop Blood Diagnostics...II-78
1$100
   Wyndgate Signs Agreement with Cameron Hospital...II-79
Daxor’s Subsidiary Wins Corporate Blood Banking Contract from Taglich Brothers...II-79
Baxter and American Red Cross Enter Into Agreement...II-79
CSL Signs Agreement with National Blood Authority...II-79
Chiron Finds a South African Partner for Procleix® Tigris®...II-79
1$100
   ThermoGenesis and BHHTI Jointly Market CryoSeal FS...II-80
Baxter and Cerus Enter into a Marketing Agreement...II-80
Haemonetics Signs Technology Alliance with ZLB Plasma Services...II-80
BioTime Collaborates with Summit Pharmaceuticals International Corp....II-80
SurgiLance Bags a Contract from America’s Blood Centers...II-80
Florida’s Blood Centers Acquire Lake Park-based South Florida Blood Banks...II-80
1$100
   Global Med Technologies’ Division Signs Agreement with Hospital Partners of
  America...II-81
Radiometer America and Consorta Extend Blood-Gas Products Deal...II-81
Baxter's ALYX System Wins Medical Design Excellence Award...II-81
Terumo Corp. Ups Stake in Blood Bag Venture...II-81
Vita 34 International AG Takes over the Holdings of Corcell and Vita 34...II-81
1$100
   CSL Acquires Aventis Behring...II-82
Medsurge Medical Products Corp. Buys Cryo Genomics...II-82
Haemonetics’ Acquisition of Harvest Technologies Expands Surgical Blood Salvage
  Portfolio...II-82
Chiron Buys Prion Solutions...II-82
Celmed & Gambro Tie up for GvHD Prevention System...II-82
Chiron Grants NAT Licenses to LabCorp and German Red Cross...II-82
1$100
   Sekisui Chemical Ventures into Chinese Blood Collection Market...II-83
Stratec and Biotest Partner on the Development of a Blood Grouping Analyzer...II-83
PRDT, ARC & Maco Pharma in a Strategic Alliance...II-83
Pall’s Enhanced Bacterial Detection System to be Marketed by Kawasumi...II-83
1$100
   Baxter and Cerus Rope in Bioone Corp for Marketing Intercept...II-84
Chiron Partners with ZymeQuest...II-84
Pall Corporation Signs Agreement with Haemonetics Corporation...II-84
Haemonetics Corporation & Hemosystem SA in a Marketing Alliance...II-84
Chiron’s Armor Strengthened with Infectio’s Rapid Bacterial Detection Licenses...II-84
1$100
   Haemonetics, Braemed and Caster in a Marketing Agreement for Cell Saver® 5...II-85
Haemonetics Obtains Marketing Licenses for Crit Scan®...II-85
Lifebank Receives AABB Accreditation...II-85
Bayer Divests Plasma Products Business to NPS...II-85
1$100
   ITL Receives FDA Clearance to Market SSK...II-86
Chronix Biomedical Files Patent Approval for a New Diagnostic Test...II-86
ViaCell’s Selective Amplification™ Program Boosts Cord Blood Banks’
  Productivity...II-86
CordLife Opens Second Cord Blood Banking Facility Singapore...II-86
PharmaStem Inks Multiple Licensing Deals for Cord blood Preservation
  Technologies...II-86
Novation Bags Big Ticket Deals for Blood Products...II-86
1$100
  12. Focus on Select Global Players...II-8714 $800  
   Leading Blood Banks...II-87
AABB (USA)...II-87
America’s Blood Centers (USA)...II-87
American Red Cross (USA)...II-87
1$100
   Canadian Blood Services (Canada)...II-88
CorCell Companies Inc. (USA)...II-88
Cord Blood Registry (USA)...II-88
1$100
   Japan Red Cross (Japan)...II-89
Lifebank Corp (Canada)...II-89
National Blood Foundation (USA)...II-89
1$100
   New England Cord Blood Bank, Inc. (USA)...II-90
New York Blood Center (USA)...II-90
VITA 34 AG (Germany)...II-90
1$100
   Leading Players in Blood Bank Technology & Supplies...II-91
Beckman Coulter Inc (USA)...II-91
Becton Dickinson (USA)...II-91
BioMerieux SA (France)...II-91
Caridian BCT, Inc (USA)...II-91
1$100
   Chiron (USA)...II-92
CSL Behring LLC (USA)...II-92
1$100
   Daxor Corporation (USA)...II-93
Fenwal Inc., (USA)...II-93
Fresenius SE (Germany)...II-93
1$100
   Gambro AB (Sweden)...II-94
Gen-Probe Incorporated (USA)...II-94
Haemonetics Corp., (USA)...II-94
1$100
   Hemagen Diagnostics Inc. (USA)...II-95
Immucor Inc. (USA)...II-95
1$100
   Kawasumi Laboratories, Inc. (Japan)...II-96
Olympus America, Inc. (USA)...II-96
PharmaStem Therapeutics, Inc. (USA)...II-96
Terumo Corporation (Japan)...II-96
1$100
   ThermoGenesis Corp. (USA)...II-97
ZymeQuest, Inc. (USA)...II-97
Leading Players in Plasma Fractionation...II-97
Baxter International Inc. (USA)...II-97
1$100
   Bio Products Laboratory (UK)...II-98
CSL Limited (Australia)...II-98
CSL Bioplasma (Australia)...II-98
Grifols (Spain)...II-98
1$100
   Kedrion (Italy)...II-99
Laboratoire Français du Fractionnement et des Biotechnologies (France)...II-99
Octapharma (Switzerland)...II-99
1$100
   Sanquin (The Netherlands)...II-100
Talecris Biotherapeutics (USA)...II-100
1$100
  13. Global Market Perspective...II-101   
   Table 17: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)...II-1011$300
   Table 18: World Long-term Projections for Blood Banking and Blood Products by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)...II-1021$300
   Table 19: World Historic Review for Blood Banking and Blood Products by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)...II-1031$300
   Table 20: World 15-Year Perspective for Blood Banking and Blood Products by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)...II-1041$300
   Table 21: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)...II-1051$300
   Table 22: World Long-term Projections for Blood Components and Plasma Products by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)...II-1061$300
   Table 23: World Historic Review for Blood Components and Plasma Products by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)...II-1071$300
   Table 24: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Group – Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)...II-108

Table 25: World Long-term Projections for Blood Components and Plasma Products by Product Group – Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)...II-108
1$300
   Table 26: World Historic Review for Blood Components and Plasma Products by Product Group – Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)...II-1091$300
   Table 27: World 15-Year Perspective for Blood Components and Plasma Products by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)...II-110

Table 28: World 15-Year Perspective for Blood Components and Plasma Products by Product Group – Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 1998, 2008 & 2012...II-110
1$300
   Table 29: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)...II-1111$300
   Table 30: World Long-term Projections for Whole Blood & Cellular Components by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)...II-1121$300
   Table 31: World Historic Review for Whole Blood & Cellular Components by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)...II-1131$300
   Table 32: World 15-Year Perspective for Whole Blood & Cellular Components by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)...II-1141$300
   Table 33: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)...II-1151$300
   Table 34: World Long-term Projections for Plasma Fractions by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)...II-1161$300
   Table 35: World Historic Review for Plasma Fractions by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)...II-1171$300
   Table 36: World 15-Year Perspective for Plasma Fractions by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)...II-1181$300
   Table 37: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)...II-1191$300
   Table 38: World Long-term Projections for Equipment, Blood Tests and Other Consumables by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)...II-1201$300
   Table 39: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)...II-1211$300
   Table 40: World 15-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)...II-1221$300
III. MARKET123$1950
  1. The United States...III-143 $1625  
   A. Market Analysis...III-1
Current and Future Analysis...III-1
Market Trends...III-1
US Blood Collection & Supply Profile...III-1
Blood Group Distribution...III-1
1$75
   Table 41: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart)...III-2

Table 42: Percentage Break up of Rh Blood Types in the US by Racial Group...III-2
Blood Donated and Transfused Every Year...III-2
Males Form the Major Chunk of Donors...III-2
1$150
   Cost of Blood...III-3
SARS Scares: Blood Banks Feel the Heat...III-3
Blood and Blood Preparations: Trade Statistics...III-3
Table 43: US Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by Country – Germany, UK, Canada, Switzerland, Belgium and Others (In US$ Million) (includes corresponding Graph/Chart)...III-3
1$150
   Table 44: US Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country – Germany, Netherlands, UK, Switzerland, Canada and Others (In US$ Million) (includes corresponding Graph/Chart)...III-4
Whole Human Blood: Export-Import Scenario in the Recent Past...III-4
1$150
   Table 45: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Volume Exports by Country – France, Canada, UK, Germany, Japan, Taiwan, Korea, Belgium, Netherlands, Italy, Peru, and Others (includes corresponding Graph/Chart)...III-51$150
   Table 46: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Value Exports by Country – France, UK, Germany, Japan, Canada, Belgium, Korea, Peru, Taiwan, Netherlands, Italy, and Others (includes corresponding Graph/Chart)...III-6

Table 47: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Volume Imports by Country – Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)...III-6
1$150
   Table 48: US Market for Whole Human Blood 2003 & 2004): Percentage Breakdown of Consumption of Value Imports by Country – Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)...III-7
US Blood Components and Plasma Market Analysis in Units...III-7
Table 49: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category – Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)...III-7
1$150
   Table 50: US 10-Year Perspective for Blood Components and Plasma by Product Category – Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)...III-8
Regulations Control Plasma Collection Industry...III-8
Product Launches/Developments...III-8
4$400
   Strategic Corporate Developments...III-1218$850
   Select Players...III-30
Blood Banks...III-30
AABB...III-30
1$75
   America’s Blood Centers...III-31
American Red Cross...III-31
1$75
   Blood Bank of Alaska...III-32
California Cryobank...III-32
Family Cord Blood Services Inc....III-32
1$75
   Community Blood Bank...III-33
CorCell Companies Inc....III-33
Cord Blood Registry...III-33
National Blood Foundation...III-33
1$75
   New England Cord Blood Bank, Inc....III-34
New York Blood Center...III-34
Oklahoma Blood Institute...III-34
1$75
   Blood Bank Technology Developers and Consumables Suppliers...III-35
Beckman Coulter Inc....III-35
Becton, Dickinson and Company...III-35
Caridian BCT, Inc...III-35
1$75
   Chiron...III-36
CSL Behring LLC (USA)...III-36
1$75
   Daxor Corporation...III-37
Fenwal Inc.,...III-37
Gen-Probe Incorporated...III-37
1$75
   Haemonetics Corp.,...III-38
Hemagen Diagnostics Inc....III-38
Immucor Inc....III-38
1$75
   Olympus America, Inc....III-39
Pall Corporation...III-39
PharmaStem Therapeutics, Inc....III-39
1$75
   ThermoGenesis Corp....III-40
ViaCell, Inc....III-40
ZymeQuest, Inc....III-40
1$75
   Major Plasma Fractionators...III-41
Baxter International Inc....III-41
Talecris Biotherapeutics...III-41
1$75
   B. Market Analytics...III-42
Table 51: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)...III-42

Table 52: US Long-term Projections for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)...III-42
1$150
   Table 53: US Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)...III-43

Table 54: US 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)...III-43
1$150
  2. Canada...III-448 $675  
   A. Market Analysis...III-44
Current and Future Analysis...III-44
Blood Facts...III-44
Bleeding Disorders – A Major Threat...III-44
The ‘CSA-Z 902-04’ – A Comprehensive Voluntary Blood Safety Standard...III-44
1$75
   Blood and Blood Preparations: Import & Export Scenario...III-45
Table 55: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by Country – US, The Netherlands, Switzerland, Belgium, Italy and Others (In US$ Million) (includes corresponding Graph/Chart)...III-45

Table 56: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country – US, France, Chile, Belgium, Germany and Others (In US$ Million) (includes corresponding Graph/Chart)...III-45
1$150
   Product Launches/Developments...III-46
Strategic Corporate Developments...III-46
2$150
   Select Players...III-48
LifeBank...III-48
Canadian Blood Services...III-48
1$75
   The Canadian Hemophilia Society (CHS)...III-49
B. Market Analytics...III-49
Table 57: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)...III-49
1$150
   Table 58: Canadian Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment – Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)...III-50

Table 59: Canadian Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)...III-50
1$150
   Table 60: Canadian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment – Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)...III-51
1$150
  3. Japan...III-525 $425  
   A. Market Analysis...III-52
Current and Future Analysis...III-52
Growing Market for Fresh Frozen Plasma...III-52
Strategic Corporate Developments...III-52
1$75
   Select Players...III-53
Japan Red Cross...III-53
Kawasumi Laboratories, Inc....III-53
Terumo Corporation...III-53
1$75
   B. Market Analytics...III-54
Table 61: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)...III-54
1$150
   Table 62: Japanese Long-term Projections for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)...III-55

Table 63: Japanese Historic Review for Blood Banking and Blood Products by Product Group/Segment – Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)...III-55